References
- An WG., Kanekal M, Simon MC, et al (1998). Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature, 392, 405-8. https://doi.org/10.1038/32925
- Baglole CJ, Maggirwar SB, Gasiewicz TA, et al (2008). The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem, 283, 28944-57. https://doi.org/10.1074/jbc.M800685200
- Bishop JA, Ogawa T, Chang X, et al (2012). HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol, 36, 142-8. https://doi.org/10.1097/PAS.0b013e3182395c7b
- Braspenning J, Marchini A, Albarani V, et al (1998). The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells. Oncogene, 16, 1085-9. https://doi.org/10.1038/sj.onc.1201617
- Budde A, Schneiderhan-Marra N, Petersen G, et al (2005). Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1). Oncogene, 24, 1802-8. https://doi.org/10.1038/sj.onc.1208369
- Buonomo T, Carraresi L, Rossini M, et al (2011). Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins. J Transl Med, 9, 2. https://doi.org/10.1186/1479-5876-9-2
- Carraresi L, Martinelli R, Vannoni A, et al (2006). Establishment and characterization of murine small cell lung carcinoma cell lines derived from HPV-16 E6/E7 transgenic mice. Cancer Lett, 231, 65-73. https://doi.org/10.1016/j.canlet.2005.01.027
- Chang YH, Yu CW, Lai LC, et al (2010). Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer. Cancer, 116, 4800-9. https://doi.org/10.1002/cncr.25224
- Chen D, Li M, Luo J, et al (2003). Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem, 278, 13595-8. https://doi.org/10.1074/jbc.C200694200
- Chen D, Tian T, Wang H, et al (2009). Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet Genomics, 19, 25-34. https://doi.org/10.1097/FPC.0b013e328316d8d8
- Chen PH, Chang H, Chang JT, et al (2012). Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer. Oncogene, 31, 2555-65. https://doi.org/10.1038/onc.2011.438
- Cheng YW, Chiou HL, Chen JT, et al (2004). Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. Lung Cancer, 46, 165-70. https://doi.org/10.1016/j.lungcan.2004.03.023
- Cheng YW, Chiou HL, Sheu GT, et al (2001). The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res, 61, 2799-803.
- Cheng YW, Lee H, Shiau MY, et al (2008). Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer. Clin Cancer Res, 14, 4705-12. https://doi.org/10.1158/1078-0432.CCR-07-4675
- Cheng YW, Wu MF, Wang J, et al (2007). Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res, 67, 10686-93. https://doi.org/10.1158/0008-5472.CAN-07-1461
- Cheng YW, Wu TC, Chen CY, et al (2008). Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis. Clin Cancer Res, 14, 7173-9. https://doi.org/10.1158/1078-0432.CCR-08-0850
- Chiou HL, Wu MF, Liaw YC, et al (2003). The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer, 97, 1558-63. https://doi.org/10.1002/cncr.11191
- Ciotti M, Giuliani L, Ambrogi V, et al (2006). Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep, 16, 183-9.
- Ciotti M, Marzano V, Giuliani L, et al (2009). Proteomic investigation in A549 lung cell line stably infected by HPV16E6/E7 oncogenes. Respiration, 77, 427-39. https://doi.org/10.1159/000176209
- De Silva R, Whitaker NJ, Rogan EM, et al (1994). HPV-16 E6 and E7 genes, like SV40 early region genes, are insufficient for immortalization of human mesothelial and bronchial epithelial cells. Exp Cell Res, 213, 418-27. https://doi.org/10.1006/excr.1994.1218
- Dynan WS, Tjian R (1983). The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell, 35, 79-87. https://doi.org/10.1016/0092-8674(83)90210-6
- Eichten A, Westfall M, Pietenpol JA, et al (2002). Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. Virology, 295, 74-85. https://doi.org/10.1006/viro.2002.1375
- Fei Y, Yang J, Hsieh WC, et al (2006). Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol, 36, 274-9. https://doi.org/10.1093/jjco/hyl017
- Gomez-Manzano C, Fueyo J, Jiang H, et al (2003). Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann Neurol, 53, 109-17. https://doi.org/10.1002/ana.10396
- Gonzalez SL, Stremlau M, He X, et al (2001). Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol, 75, 7583-91. https://doi.org/10.1128/JVI.75.16.7583-7591.2001
- Goto A, Li CP, Ota S, et al (2011). Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J Med Virol, 83, 1383-90. https://doi.org/10.1002/jmv.22150
- Guo F, Fan Y, Qiao Y, et al (2012). [Study advance of relationship between HPV and lung cancer]. Zhongguo Fei Ai Za Zhi, 15, 191-4.
- Helt AM, Funk JO, Galloway DA (2002). Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J Virol, 76, 10559-68. https://doi.org/10.1128/JVI.76.20.10559-10568.2002
- Hoenil Jo, K JW (2005). Implications of HPV infection in uterine cervical cancer. Cancer Therapy Vol, 3, 419-34.
- Ikezoe T, Chen SS, Tong XJ, et al (2003). Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol, 23, 1187-93.
- Iwakawa R, Kohno T, Enari M, et al (2010). Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma. Cancer Sci, 101, 1891-16. https://doi.org/10.1111/j.1349-7006.2010.01622.x
- Jones DL, Thompson DA, Suh-Burgmann E, et al (1999). Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway. Virology, 258, 406-14. https://doi.org/10.1006/viro.1999.9733
- Jones EE, Wells SI (2006). Cervical cancer and human papillomaviruses: inactivation of retinoblastoma and other tumor suppressor pathways. Curr Mol Med, 6, 795-808.
- Kalmes M, Hennen J, Clemens J, et al (2011). Impact of aryl hydrocarbon receptor (AhR) knockdown on cell cycle progression in human HaCaT keratinocytes. Biol Chem, 392, 643-51.
- Kato T, Koriyama C, Khan N, et al (2012). EGFR mutations and human papillomavirus in lung cancer. Lung Cancer, 78, 114-7
- Kim JH, Kim H, Lee KY, et al (2007). Aryl hydrocarbon receptor gene polymorphisms affect lung cancer risk. Lung Cancer, 56, 9-15. https://doi.org/10.1016/j.lungcan.2006.11.010
- KinjomT, Kamiyama K, Chinen K, et al (2003). Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells. Mol Pathol, 56, 97-108. https://doi.org/10.1136/mp.56.2.97
- Koshiol J, Rotunno M, Gillison ML, et al (2011). Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst, 103, 501-7. https://doi.org/10.1093/jnci/djr003
- Kyo S, Takakura M, Fujiwara T, et al (2008). Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci, 99, 1528-38. https://doi.org/10.1111/j.1349-7006.2008.00878.x
- Li G, He L, Zhang E, et al (2011). Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1alpha and VEGF expression in non-small cell lung cancer cells. Cancer Lett, 311, 160-70. https://doi.org/10.1016/j.canlet.2011.07.012
- Lin P, Chang H, Ho WL, et al (2003). Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers. Lung Cancer, 42, 255-61. https://doi.org/10.1016/S0169-5002(03)00359-3
- Lin P, Chang H, Tsai WT, et al (2003). Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxicol Pathol, 31, 22-30. https://doi.org/10.1080/01926230309746
- Liu X, Clements A, Zhao K, et al (2006). Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem, 281, 578-86. https://doi.org/10.1074/jbc.M508455200
- Liu X, Disbrow GL, Yuan H, et al (2007). Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes. J Virol, 81, 12689-95. https://doi.org/10.1128/JVI.00669-07
- McMurray HR, McCance DJ (2003). Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol, 77, 9852-61. https://doi.org/10.1128/JVI.77.18.9852-9861.2003
- Munoz JP, Gonzalez C, Parra B, et al (2012). Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells. PLoS One, 7, e38178. https://doi.org/10.1371/journal.pone.0038178
- Numasaki M, Fukushi J, Ono M, et al (2003). Interleukin-17 promotes angiogenesis and tumor growth. Blood, 101, 2620-7. https://doi.org/10.1182/blood-2002-05-1461
- Numasaki M, Watanabe M, Suzuki T, et al (2005). IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol, 175, 6177-89. https://doi.org/10.4049/jimmunol.175.9.6177
- Nunobiki O, Ueda M, Toji E, et al (2011). Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis. Patholog Res Int, 2011, 364069.
- Ohtsuka K, Ohnishi H, Furuyashiki G, et al (2006). Clinicopathological and biological significance of tyrosine kinase domain gene mutations and overexpression of epidermal growth factor receptor for lung adenocarcinoma. J Thorac Oncol, 1, 787-95. https://doi.org/10.1097/01243894-200610000-00006
- Park JS, Kim EJ, Lee JY, et al (2001). Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int J Cancer, 91, 822-7. https://doi.org/10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0
- Park MS, Chang YS, Shin JH, et al (2007). The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J, 48, 69-77. https://doi.org/10.3349/ymj.2007.48.1.69
- Phelps WC, Yee CL, Munger K, et al (1988). The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell, 53, 539-47. https://doi.org/10.1016/0092-8674(88)90570-3
- Podechard N, Lecureur V, Le Ferrec E, et al (2008). Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. Toxicol Lett, 177, 130-7. https://doi.org/10.1016/j.toxlet.2008.01.006
- Puga A, Xia Y, Elferink C (2002). Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact, 141, 117-30. https://doi.org/10.1016/S0009-2797(02)00069-8
- Razani B, Altschuler Y, Zhu L, et al (2000). Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry, 39, 13916-24. https://doi.org/10.1021/bi001489b
- Saini N, Srinivasan R, Chawla Y, et al (2009). Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver Int, 29, 1162-70. https://doi.org/10.1111/j.1478-3231.2009.02082.x
- Sanchez-Puig N, Veprintsev DB, Fersht AR (2005). Binding of natively unfolded HIF-1alpha ODD domain to p53. Mol Cell, 17, 11-21. https://doi.org/10.1016/j.molcel.2004.11.019
- Sen S, Reddy VG, Guleria R, et al (2002). Telomerase--a potential molecular marker of lung and cervical cancer. Clin Chem Lab Med, 40, 994-1001.
- Shimoda LA, Semenza GL (2011). HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med, 183, 152-6. https://doi.org/10.1164/rccm.201009-1393PP
- Srinivasan M, Taioli E, Ragin CC (2009). Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis. Carcinogenesis, 30, 1722-28. https://doi.org/10.1093/carcin/bgp177
- Syrjanen K (2012). Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res, 32, 3235-50.
- Syrjanen K, Silvoniemi M, Salminen E, et al (2012). Detection of human papillomavirus genotypes in bronchial cancer using sensitive multimetrix assay. Anticancer Res, 32, 625-31.
- Thomas M, Glaunsinger B, Pim D, et al (2001). HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene, 20, 5431-39. https://doi.org/10.1038/sj.onc.1204719
- Thomas MC, Chiang CM (2005). E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell, 17, 251-64. https://doi.org/10.1016/j.molcel.2004.12.016
- Todorovic B, Massimi P, Hung K, et al (2011). Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation. J Virol, 85, 10048-57. https://doi.org/10.1128/JVI.00643-11
- Veldman T, Horikawa I, Barrett JC, et al (2001). Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol, 75, 4467-72. https://doi.org/10.1128/JVI.75.9.4467-4472.2001
- Walker J, Smiley LC, Ingram D, et al (2011). Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration. Virology, 410, 283-90. https://doi.org/10.1016/j.virol.2010.11.010
- Wang H, Qiao YL (2007). [Human papillomavirus types and their related diseases]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 29, 678-84.
- Wang J, Cheng YW, Wu DW, et al (2006). Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected nonsmoking female lung cancer in Taiwan. Cancer Lett, 235, 18-25. https://doi.org/10.1016/j.canlet.2005.03.058
- Wang Y, Wang A, Jiang R, et al (2008). Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep, 20, 333-9.
- Watabe Y, Nazuka N, Tezuka M, et al (2010). Aryl hydrocarbon receptor functions as a potent coactivator of E2F1-dependent trascription activity. Biol Pharm Bull, 33, 389-97. https://doi.org/10.1248/bpb.33.389
- Wu DW, Liu WS, Wang J, et al (2011). Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirusassociated lung cancer. Clin Cancer Res, 17, 1895-905. https://doi.org/10.1158/1078-0432.CCR-10-2316
- Wu HH, Wu JY, Cheng YW, et al (2010). cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/ phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer. Clin Cancer Res, 16, 5200-10. https://doi.org/10.1158/1078-0432.CCR-10-0020
- Yuan H, Fu F, Zhuo J, et al (2005). Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene, 24, 5069-78. https://doi.org/10.1038/sj.onc.1208691
- Zhang Y, Dasgupta J, Ma RZ, et al (2007). Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol, 81, 3618-26. https://doi.org/10.1128/JVI.02044-06
- Zimmermann H, Degenkolbe R, Bernard HU, et al (1999). The human papillomavirus type 16 E6 oncoprotein can downregulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol, 73, 6209-19.
- zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-50. https://doi.org/10.1038/nrc798
- zur Hausen H (2009). Papillomaviruses in the causation of human cancers -a brief historical account. Virology, 384, 260-5. https://doi.org/10.1016/j.virol.2008.11.046
Cited by
- Human Papillomavirus Genotypes Associated with Mucopurulent Cervicitis and Cervical Cancer in Hangzhou, China vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3603
- Reversal of Resistance towards Cisplatin by Curcumin in Cervical Cancer Cells vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1403
- Pathways and Delayed Cyclin B1 Nuclear Translocation vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4101
- The Role of Human Papilloma Virus (HPV) Infection in Non-Anogenital Cancer and the Promise of Immunotherapy: A Review vol.33, pp.5, 2014, https://doi.org/10.3109/08830185.2014.911857
- Hepatitis C virus core protein induces hypoxia-inducible factor 1α-mediated vascular endothelial growth factor expression in Huh7.5.1 cells vol.9, pp.5, 2014, https://doi.org/10.3892/mmr.2014.2039
- Activities of E6 Protein of Human Papillomavirus 16 Asian Variant on miR-21 Up-regulation and Expression of Human Immune Response Genes vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3961
- Involvement of TP53 and TP16 expression in human papillomavirus-associated non-small cell lung cancer vol.12, pp.5, 2016, https://doi.org/10.3892/ol.2016.5087